TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
IMTX

Immatics NV

Healthcare · Biotechnology

8.50$ +1.6% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement IMTX
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– +389.4% +69.4% +11.2% +397.2% -68.8% +188.6% -69.0%
– +18.0% +67.3% +30.5% +21.9% +11.1% +24.8% –
– – – – +397.2% -68.8% +188.6% -69.0%
– +18.0% +67.3% +30.5% +21.9% +11.1% +24.8% +24.1%
– +53.4% +190.4% -1.0% +6.9% +5.7% +21.6% +10.2%
– +34.8% -34.2% +257.3% +18.0% +9.0% +24.9% +18.4%
– – – – – -439.6% – –
– +962.5% +70.0% +95.8% +83.4% -19.9% +6.6% +6.8%
– – – – – -330.7% – -1,029.6%
– – – – +730.4% -116.4% – -132.5%
– – – – – -441.7% – -1,390.9%
– – – – – -277.7% – -637.2%

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?